-- Acıbadem Healthcare Group, a globally recognized network of Joint Commission International (JCI) accredited hospitals, today highlighted its expanded patient-centered services in advanced cancer diagnosis, systemic therapies, and personalized oncological care. Through its specialized Medical Oncology department, Acıbadem continues to set international benchmarks by delivering tailored treatment strategies that address the unique molecular and biological profile of each patient’s disease.
Medical oncology serves as the cornerstone of modern cancer care, managing the diagnosis, staging, systemic treatment, and long-term follow-up of various malignancies. At Acıbadem International, treatment protocols extend far beyond conventional chemotherapy to include innovative options such as immunotherapy, targeted smart drugs, hormone therapy, and biological agents.
Multidisciplinary Expertise & Precision Medicine
Central to Acıbadem’s clinical philosophy is its multidisciplinary tumor board model. Each patient case is thoroughly reviewed by a collaborative panel of medical oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists, and genetic specialists. This joint assessment ensures a precise, step-by-step treatment strategy designed to maximize therapeutic outcomes while prioritizing patient comfort and quality of life.
Key highlights of the department include:
- Advanced Diagnostic Capabilities: Utilizing 3T MRI, high-resolution PET-CT, molecular pathology, and genetic profiling for precise tumor characterization.
- Targeted & Immunotherapy Modalities: Deploying smart drugs that selectively target cancer cells while minimizing damage to healthy surrounding tissue.
- Therapeutic Synergy: Seamless integration with state-of-the-art technologies, including MRIdian (real-time MRI-guided radiation therapy) and Da Vinci Robotic Surgery.
- Comprehensive Care Management: Offering dedicated palliative care, symptom control, and survivorship monitoring throughout every stage of treatment.
Tailored Services for International Patients
Having treated over one million international patients from more than 90 countries, Acıbadem’s International Patient Service Center operates as a dedicated "one-stop center". Foreign patients receiving care within the Medical Oncology department benefit from 24/7 multilingual support, pre-travel medical document evaluations, second opinions, travel and accommodation assistance, and structured post-treatment follow-up.
"Effective cancer treatment requires more than standard clinical protocols; it demands a deep, individualized understanding of the tumor at a molecular level," said an Oncology Specialist at Acıbadem Healthcare Group. "By combining innovative drug therapies with multidisciplinary tumor board oversight, we provide our patients with world-class medical care tailored to their specific needs."
About Acıbadem Healthcare Group
Acıbadem Healthcare Group is a global leader in healthcare services, operating a wide network of modern hospitals and outpatient centers. Accredited by Joint Commission International (JCI) and ISO certified, Acıbadem is renowned for excellence across complex specialties, including medical oncology, radiation oncology, organ transplantation, cardiology, and robotic surgery.
To learn more about diagnostic capabilities, personalized therapies, or international consultation services, visit the official Medical Oncology department portal.
Contact Info:
Name: ACIBADEM
Email: Send Email
Organization: ACIBADEM
Address: Istanbul, Turkey
Phone: +90 216 544 46 64
Website: https://acibademinternational.com/
Release ID: 89202378
Google
RSS